Truvestments Capital’s VanEck Biotech ETF BBH Stock Holding History

Truvestments Capital’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$44.7K	Hold	220	–	–	0.01%	553
2026 Q1	$41.4K	Hold	220	–	–	0.01%	525
2025 Q4	$41.6K	Hold	220	–	–	0.01%	483
2025 Q3	$36.5K	Sell	220 -30	-12%	-$4.89K	0.01%	490
2025 Q2	$38.3K	Hold	250	–	–	0.01%	436
2025 Q1	$39.3K	Hold	250	–	–	0.01%	442
2024 Q4	$39.2K	Hold	250	–	–	0.01%	409
2024 Q3	$44.3K	Buy	+250	New	+$44.4K	0.01%	372
2024 Q2	–	Sell	-250	Closed	-$41.6K	–	269
2024 Q1	$41.6K	Hold	250	–	–	0.02%	369
2023 Q4	$41.3K	Hold	250	–	–	0.02%	344
2023 Q3	$38.9K	Hold	250	–	–	0.02%	307
2023 Q2	$39K	Hold	250	–	–	0.02%	313
2023 Q1	$40.5K	Hold	250	–	–	0.02%	307
2022 Q4	$39.9K	Hold	250	–	–	0.02%	320
2022 Q3	$35K	Hold	250	–	–	0.02%	288
2022 Q2	$36K	Buy	+250	New	+$37.2K	0.02%	288
2022 Q1	–	Sell	-250	Closed	-$47K	–	217
2021 Q4	$47K	Hold	250	–	–	0.02%	274
2021 Q3	$51K	Hold	250	–	–	0.03%	249
2021 Q2	$50K	Sell	250 -25	-9%	-$4.65K	0.03%	249
2021 Q1	$48K	Hold	275	–	–	0.03%	283
2020 Q4	$46K	Buy	+275	New	+$45.3K	0.03%	271
2020 Q3	–	Sell	-275	Closed	-$44K	–	345
2020 Q2	$44K	Buy	+275	New	+$41.8K	0.04%	219
2019 Q4	–	Sell	-275	Closed	-$32K	–	182
2019 Q3	$32K	Hold	275	–	–	0.02%	323
2019 Q2	$35K	Buy	+275	New	+$33.9K	0.02%	331

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Truvestments Capital's BBH Position: Q2 2026 in Review

Truvestments Capital held its VanEck Biotech ETF (BBH) position steady in Q2 2026 at 220 shares worth $44.7K. The position accounts for 0.01% of the portfolio, ranked #553.

Truvestments Capital first reported a position in BBH in Q2 2019 and has held it in 24 quarters since. The position peaked at $51K in Q3 2021. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

Truvestments Capital held 220 shares of VanEck Biotech ETF worth $44.7K as of Q2 2026.
Truvestments Capital left its VanEck Biotech ETF share count unchanged in Q2 2026.
VanEck Biotech ETF made up 0.01% of Truvestments Capital's portfolio in Q2 2026, its #553 holding.
Truvestments Capital first reported a position in VanEck Biotech ETF in Q2 2019 and has held it in 24 quarters since.
Truvestments Capital's VanEck Biotech ETF position peaked at $51K in Q3 2021.
110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.